Aura Biosciences, Inc.Aura Biosciences, Inc.Aura Biosciences, Inc.

Aura Biosciences, Inc.

No trades
See on Supercharts
Market capitalization
‪373.26 M‬USD
−1.93USD
‪−76.41 M‬USD
‪39.71 M‬
Beta (1Y)
3.88

About Aura Biosciences, Inc.

CEO
Elisabet de los Pinos
Headquarters
Boston
Employees (FY)
89
Founded
2007
ISIN
US05153U1079
FIGI
BBG00226DGM5
Aura Biosciences, Inc. is a clinical-stage oncology company, which engages in developing a novel technology platform based on virus-like drug conjugates (VDCs) to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity. The firm's product candidate belzupacap sarotalocan (AU-011) is in Phase 2 development for the first line treatment of choroidal melanoma, a vision and life-threatening form of eye cancer where standard of care radioactive treatments leave patients with major vision loss and severe comorbidities. The was founded by Elisabet de los Pinos in 2007 and is headquartered in Boston, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AURA is 7.55 USD — it has increased by 0.13% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Aura Biosciences, Inc. stocks are traded under the ticker AURA.
Aura Biosciences, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Aura Biosciences, Inc. has a max estimate of 21.00 USD and a min estimate of 19.00 USD.
AURA earnings for the last quarter are −0.48 USD whereas the estimation was −0.52 USD which accounts for 7.83% surprise. Estimated earnings for the next quarter are −0.42 USD. See more details about Aura Biosciences, Inc. earnings.
Yes, you can track Aura Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, AURA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aura Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
AURA reached its all-time high on Nov 16, 2021 with the price of 26.16 USD, and its all-time low was 5.99 USD and was reached on Nov 7, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 89.00 employees. See our rating of the largest employees — is Aura Biosciences, Inc. on this list?